iOS app Android app

Breast Cancer Drug

This Old Breast Cancer Drug Could One Day Cure Superbug Infections

The Huffington Post | Anna Almendrala | Posted 10.15.2015 | Healthy Living

The "superbug" MRSA has long been the scourge of hospitals. The second-leading cause of infections acquired during a stay, it can result in dangerous...

Experimental Breast Cancer Drug Succeeds In Trial

Reuters | Posted 04.05.2014 | Healthy Living

Feb 3 (Reuters) - Pfizer Inc's experimental breast cancer drug significantly improved patient survival rates in a mid-stage trial wi...

Data Supports Fast Approval For Breast Cancer Drug, FDA Reviewers Say

Reuters | Posted 11.10.2013 | Healthy Living

Sept 10 (Reuters) - Trial data on Swiss drugmaker Roche's breast cancer treatment Perjeta supported a faster approval of the drug f...

FDA Approves First-Of-Its-Kind Breast Cancer Drug

AP | MATTHEW PERRONE | Posted 02.18.2014 | Healthy Living

The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones. The dru...

Breast Cancer Drug Extends Overall Survival, Study Finds

Reuters | Posted 02.09.2013 | Healthy Living

ZURICH, Dec 8 (Reuters) - Swiss pharma group Roche's drug Perjeta significantly extended the lives of women with an aggressive and incurable form o...

Drug Delays Progression Of Most Common Form Of Breast Cancer

Reuters | Posted 02.05.2013 | Healthy Living

By Ransdell Pierson Dec 5 (Reuters) - An experimental drug showed impressive effectiveness and safety in a mid-stage trial against a c...

FDA Approves Novartis Drug Afinitor For Breast Cancer

Reuters | Posted 09.19.2012 | Healthy Living

July 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Novartis AG's drug Afinitor to treat women with a certain t...

Novel Drug Shows Promise in Her2+ Form of Breast Cancer

Dr. Elaine Schattner | Posted 08.06.2012 | Healthy Living
Dr. Elaine Schattner

A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.

Science Has the Answer -- Depending on the Question

Michael D. Fayer | Posted 02.17.2012 | Politics
Michael D. Fayer

In making her decision on Plan B, Kathleen Sebelius did not say that the FDA's science was wrong or that she had her own experts who disagreed with the FDA. She was making a policy decision, not a scientific decision.

'It's Tough Enough To Have The Uncertainty of life and death'

AP | MARCUS WOHLSEN | Posted 12.11.2011 | San Francisco

Marcus Wohlsen, Associated Press SAN FRANCISCO (AP) — For the past 2½ years, Terry Kalley's wife has battled breast cancer with Avastin, the wo...

UPDATE: FDA Votes Down Avastin For Breast Cancer

Posted 08.28.2011 | Healthy Living

UPDATE: A Food and Drug Administration panel voted today to revoke Avastin's approval for treatment of breast cancer. The panel voted 6-0 to r...

FDA Decision Could End Avastin's Role As Breast Cancer Drug

AP | By MATTHEW PERRONE | Posted 08.27.2011 | Healthy Living

WASHINGTON -- The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effor...

Can This Drug Reduce The Risk Of Breast Cancer?

AP | MARILYNN MARCHIONE | Posted 08.04.2011 | Healthy Living

CHICAGO — Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut ...

FDA Says Breast Cancer Drug Did Not Extend Lives

AP | MATTHEW PERRONE | Posted 11.17.2011 | Healthy Living

WASHINGTON — Follow-up studies of a Roche breast cancer drug showed that it failed to extend the lives of patients, federal health scientists sa...

Hope For Millions Of Women As Scientists Unlock Secrets Of Most Widely-Used Breast Cancer Drug

Daily Mail | Fiona Macrae | Posted 11.17.2011 | Healthy Living

Scientists have unlocked the secrets of the most widely-used breast cancer drug in a breakthrough that could save thousands of lives. Understanding h...